Advertisement

Topics

A closer look at the Parexel deal

09:53 EDT 21 Jun 2017 | Outsourcing-Pharma

Another day, another CRO acquisition – this time Parexel, a top 10 CRO, was acquired by Pamplona Capital, a large private equity firm.

Original Article: A closer look at the Parexel deal

NEXT ARTICLE

More From BioPortfolio on "A closer look at the Parexel deal"

Advertisement
Quick Search
Advertisement
Advertisement